ContraFect Corporation P/E Ratio 2011-2026 | CFRX

Annual P/E Ratio ContraFect Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.0166	-0.0752	-0.0531	-0.563	-1.01	-4.66	-2.06	-3.04	-1.41	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.0166	-4.66	-1.43

P/E Ratio of other stocks in the Biotechnology industry

Issuer	P/E Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.612	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	-0.236	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	55.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	2.49 K	-	2.54 %	$ 160 B	France
Autolus Therapeutics plc AUTL	-1.12	$ 1.34	-3.6 %	$ 357 M	Britain
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	-14.5	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.57	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	-0.0662	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	-19.2	$ 20.13	-1.13 %	$ 2.81 B	France
Alterity Therapeutics Limited ATHE	-66.5	$ 3.65	1.3 %	$ 8.78 B	Australia
Advaxis ADXS	-0.0388	-	-9.65 %	$ 45.9 M	USA
Dyadic International DYAI	-4.27	$ 0.87	-	$ 31.5 M	USA
Adverum Biotechnologies ADVM	-0.583	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	-1.16	$ 2.57	-3.57 %	$ 16.1 M	USA
Институт стволовых клеток человека ISKJ	38.8	-	-	-	Russia
Equillium EQ	-5.27	$ 2.04	1.24 %	$ 117 M	USA
Aeterna Zentaris AEZS	-4.94	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.00095	-	-10.17 %	$ 12.2 K	USA
Fate Therapeutics FATE	-1.37	$ 1.13	-5.04 %	$ 134 M	USA
Aeglea BioTherapeutics AGLE	-3.48	-	-	$ 1.01 B	USA
Forte Biosciences FBRX	-4.83	$ 26.57	0.49 %	$ 344 M	USA
Applied Genetic Technologies Corporation AGTC	-1.71	-	-	$ 26.5 M	USA
Fennec Pharmaceuticals FENC	-17.3	$ 6.14	-4.36 %	$ 175 M	USA
Foghorn Therapeutics FHTX	-4.79	$ 4.74	-2.87 %	$ 299 M	USA
AIkido Pharma AIKI	-1.33	-	1.93 %	$ 17.4 M	USA
Amicus Therapeutics FOLD	-163	$ 14.46	0.03 %	$ 4.46 B	USA
Aptose Biosciences APTO	-0.0913	-	-45.71 %	$ 1.2 M	Canada
Fulcrum Therapeutics FULC	-0.0072	$ 7.55	-3.58 %	$ 478 K	USA
Galectin Therapeutics GALT	-5.78	$ 2.25	-12.3 %	$ 144 M	USA
Akero Therapeutics AKRO	-12.9	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-8.58	-	-	$ 867 M	Germany
BioNTech SE BNTX	6.11	$ 87.65	-3.98 %	$ 27.2 B	Germany
Gilead Sciences GILD	21.6	$ 138.19	-1.38 %	$ 172 B	USA
Coherus BioSciences CHRS	1.35	$ 1.61	-3.59 %	$ 189 M	USA
Akari Therapeutics, Plc AKTX	-467	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	-1.98	-	0.23 %	$ 488 M	USA
Galmed Pharmaceuticals Ltd. GLMD	-0.166	$ 0.54	4.26 %	$ 503 K	Israel
Genmab A/S GMAB	33.2	$ 27.01	-2.67 %	$ 17.2 B	Danmark
Allakos ALLK	-0.612	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	-2.17	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	130	$ 314.44	-4.81 %	$ 41.2 B	USA
Gossamer Bio GOSS	-0.63	$ 0.32	-7.11 %	$ 73.1 M	USA
Grifols, S.A. GRFS	31.7	$ 7.91	-3.95 %	$ 6.83 B	Spain
Alpine Immune Sciences ALPN	-4.65	-	-	$ 2.17 B	USA
GT Biopharma GTBP	-0.0914	$ 0.42	-6.49 %	$ 2.32 M	USA
Aileron Therapeutics ALRN	-0.608	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	-0.189	-	4.14 %	$ 49.1 M	USA
Halozyme Therapeutics HALO	30.5	$ 63.51	0.68 %	$ 7.61 B	USA
Burford Capital Limited BUR	12.2	$ 4.42	-1.34 %	$ 727 M	Britain